Advertisement
The most common adverse events associated with injectable fillers are swelling and infection

Swelling, Infection Most Common Side Effects of Injectable Fillers

0
More serious adverse events include vascular compromise resulting in necrosis, blindness
Four in 10 colorectal cancer survivors report cancer-related financial stress or strain

Financial Strain, Stress High Among Colorectal CA Survivors

0
Colorectal cancer survivors with this strain, stress more likely to have low health-related quality of life
Methotrexate and azathioprine appear to be effective and safe as maintenance treatments in moderate-to-severe atopic dermatitis for up to five years

Methotrexate, Azathioprine Seem Safe Long-Term for Dermatitis

0
For up to five years as maintenance treatments for moderate-to-severe atopic dermatitis
Compared to placebo

Pioglitazone Associated With Lower Blood Leptin in Diabetes

0
In T2DM, leptin levels are lower with pioglitazone than placebo but not oral antidiabetic drugs
For individuals with insomnia symptoms

Wearing Amber Lenses Before Bed May Help With Insomnia

0
Improvements in Pittsburgh Insomnia Rating Scale and significant delay in reported wake-up time
Addressing persistent symptoms

Findings Support Comprehensive Approach for Seniors With Cancer

0
Persistent symptoms, comorbidities, leisure-time physical activity, financial challenges deemed key factors
For patients undergoing catheter ablation for nonvalvular atrial fibrillation

Interruption of Apixaban Doesn’t Impact Bleeding in A-Fib

0
Similarly low rate of thromboembolic events with uninterrupted, minimally interrupted apixaban
Varenicline is associated with reduced heavy drinking among men and with increased smoking abstinence

Varenicline Linked to Reduction in Heavy Drinking in Men

0
Also associated with smoking abstinence in overall sample of participants
From 2015 to 2016

CDC: 2015 to 2016 Saw Drop in Life Expectancy in United States

0
Increase in rate of age-adjusted drug overdose deaths observed during same time period
A levonorgestrel-releasing intrauterine device is effective in the majority of patients undergoing conservative treatment for low-risk endometrial cancer and complex atypical hyperplasia

Levonorgestrel IUD Feasible for Low-Risk, Early Uterine Cancer

0
Majority of women responded well and returned to normal histology in six months